| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $3.1M | -11.6% |
| Cost of Revenue | $2.3M | +94.2% |
| R&D Expense | $2.2M | +5.4% |
| SG&A Expense | $5.8M | -6.1% |
| Operating Income | -$7.2M | -21.9% |
| Net Income | -$7.4M | -26.8% |
| EPS (Basic) | -$0.23 | -15.0% |
| EPS (Diluted) | -$0.23 | -15.0% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $4.6M | -29.0% |
| Short-term Investments | $2.7M | -3.0% |
| Accounts Receivable | $1.1M | +360.0% |
| Current Assets | $9.9M | +0.7% |
| Total Assets | $9.9M | +0.2% |
| Current Liabilities | $3.7M | +50.6% |
| Total Liabilities | $8.7M | +16.8% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$5.7M | -43.5% |
| Investing Cash Flow | $82K | +104.4% |
| Financing Cash Flow | $5.0M | -15.1% |
| $1.2M |
| -50.1% |